Test Price
2,800 AED✅ Home Collection Available
LMNA Gene Heart-Hand Syndrome (Slovenian Type) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين LMNA لمتلازمة القلب واليد من النوع السلوفيني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – Rapid Diagnostic Precision
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS processing (LOINC 58709-2).
- Premium Logistics: Paid hospital-grade cold-chain home collection by certified VIP mobile phlebotomists, active 8 AM – 11 PM daily.
- Clinical Guidance: Complementary telephonic post-test result interpretation with a genetic counsellor.
- Insurance Assistance: Direct billing verification via WhatsApp +971 54 548 8731; most UAE policies accepted.
- يقدم هذا التحليل تشخيصاً جينياً دقيقاً لمتلازمة القلب واليد وفقاً لأعلى معايير هيئة الصحة بدبي ووزارة الصحة ووقاية المجتمع، مع ضمان خصوصية البيانات وفقاً لقانون حماية البيانات الشخصية PDPL.
Overview of LMNA Gene Heart‑Hand Syndrome Testing
The LMNA gene NGS test screens for pathogenic variants causing Heart‑Hand syndrome, Slovenian type – a rare dysmorphology disorder characterised by congenital cardiac anomalies and radial ray limb defects. This advanced next‑generation sequencing technology identifies even low‑frequency mutations, guiding accurate diagnosis, management, and reproductive planning.
يفحص تحليل الجين LMNA الطفرات المسببة لمتلازمة القلب واليد، النوع السلوفيني، مما يساعد في التشخيص الدقيق وتخطيط الرعاية الطبية للأفراد المصابين وعائلاتهم.
| Feature | Our Test – MenaLabs NGS | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full gene | Sanger sequencing, targeted exons only |
| Gene Coverage | Complete LMNA gene (all exons, intron‑exon boundaries) | Limited to known hotspots |
| Sensitivity | 99.9% | ~95% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Price | 2800 AED | Often higher with limited insurance |
| DHA/MOHAP Compliance | Fully Licensed Facility: 9834453 | Variable |
Physician Insight & Safety Protocol
"As a clinician deeply involved in paediatric cardiology and genetics, I recognise the emotional burden families carry when a child presents with cardiac and limb abnormalities. This test delivers powerful molecular confirmation, but it must always be integrated with echocardiography and a comprehensive clinical evaluation. Genetic counselling is not optional; it is essential for interpreting results and planning care."
— Dr. PRABHAKAR REDDY, Specialist (DHA Licence: 61713011)
Medication Warning
Do not discontinue prescribed medications (beta‑blockers, diuretics, antiarrhythmics, or anticoagulants) without consulting your treating physician. This test does not replace ongoing cardiac surveillance.
Exclusion Criteria & Emergency Red Flags
- Unable to provide informed consent – genetic testing on minors mandates consent from legal guardian (UAE Child Protection Law, 2026).
- Recent blood transfusion (within 2 weeks) that may compromise DNA purity.
- Active severe haemophilia or uncontrolled bleeding diathesis – relative contraindication for venipuncture.
- Individuals who decline pre‑test genetic counselling.
- ER Red Flags: Sudden chest pain, palpitations, fainting, cyanosis (bluish skin), severe breathlessness, or signs of heart failure (swelling, rapid breathing) – seek emergency medical care immediately, this test does not treat acute symptoms.
Patient FAQ & Clinical Guidance
1. What is the LMNA gene heart‑hand syndrome test and why is it performed?
15‑second summary: This NGS‑based test analyses the entire LMNA gene to detect pathogenic variants linked to Heart‑Hand syndrome, Slovenian type, enabling precise diagnosis, early intervention, and family genetic counselling.
يقوم اختبار تحليل الجين LMNA بتحديد الطفرات المرضية المرتبطة بمتلازمة القلب واليد، مما يسمح بوضع خطة علاجية مبكرة واستشارات وراثية للعائلة. يتم إجراء الاختبار على عينة دم أو حمض نووي مستخلص.
2. How is the sample collected and what is the expected turnaround time?
15‑second summary: A trained phlebotomist collects a blood sample at your home via our VIP mobile service; extracted DNA or a dry blood spot on FTA card is also accepted, with results in 3 to 4 weeks using NGS technology.
يتم جمع العينة في المنزل بواسطة أخصائي سحب دم متنقل أو يمكن تقديم حمض نووي مستخلص أو بقعة دم جافة على بطاقة FTA، وتظهر النتائج خلال 3 إلى 4 أسابيع.
3. Will my health insurance cover this genetic?
15‑second summary: Many UAE insurers cover diagnostic genetic testing when medically necessary; our team performs direct billing verification before collection via WhatsApp +971 54 548 8731.
تغطي العديد من شركات التأمين في الإمارات الفحوصات الجينية التشخيصية بناءً على توصية الطبيب، ونتولى التحقق المباشر من التغطية عبر واتساب +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians